Insights

Gathering insights about MEDS…

Similar companies to MEDS

MEDS Tech Stack

MEDS uses 8 technology products and services including Disqus, MySQL, Mailchimp, and more. Explore MEDS's tech stack below.

Disqus
Comment Systems
MySQL
Database
Mailchimp
Email
PHP
Programming Languages
Yoast SEO
Search Engines
X-XSS-Protection
Security
CivicTheme
UI Frameworks
Nginx
Web Servers

Media & News

Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
TAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced key additions to its executive leadership team and Board of Directors. These strategic appointments reflect the Company's commitment to executing on its growth strategy, enhancing operational scale, and delivering long-term shareholder value.
May 28, 2025 | www.accessnewswire.com
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced that it is changing its name to Scienture Holdings, Inc. (“Scienture Holdings”), effective Monday, September 23, 2024. Scienture Holdings stock will begin trading under the new ticker symbol NASDAQ:SCNX on September 23, 2024.
Sep 20, 2024 | www.globenewswire.com
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team
TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture's President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., MBA has been promoted to Executive VP and COO of Scienture.
Aug 05, 2024 | www.globenewswire.com
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million.
Jul 26, 2024 | www.globenewswire.com
TRxADE Health, Inc. Announces Special Cash Dividend
TAMPA, FL, July 09, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (Nasdaq: MEDS) (the “Company”), announced that the Company's board of directors has declared a special cash dividend of $1.50 per share of common stock. The special dividend is being paid using a portion of the proceeds received in May 2024 in connection with the prior sale of the Company's web-based market platform assets. The special cash dividend is payable to stockholders of record as of July 19, 2024, with the dividend being paid on or about July 24, 2024.
Jul 09, 2024 | www.globenewswire.com
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ending March 31, 2024 (the “Form 10-Q”), the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
May 29, 2024 | www.globenewswire.com
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
TAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on April 17, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year (the “Form 10-K”), the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
Apr 23, 2024 | www.globenewswire.com

MEDS's Email Address Formats

MEDS uses at least 1 format(s):

MEDS Email Formats	Example	Percentage
First.Last@er-meds.com	John.Doe@er-meds.com	97%
First.Middle@er-meds.com	John.Michael@er-meds.com	3%

Frequently Asked Questions

Where is MEDS's headquarters located?

MEDS's main headquarters is located at 320 East Highway 50 Belleville, Illinois 62269 United States. The company has employees across 5 continents, including North AmericaSouth AmericaAfrica.

What is MEDS's phone number?

You can contact MEDS's main corporate office by phone at

+1-618-624-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MEDS's stock symbol?

MEDS is a publicly traded company; the company's stock symbol is MEDS.

What is MEDS's official website and social media links?

MEDS's official website is er-meds.com and has social profiles on LinkedIn.

What is MEDS's NAICS code?

MEDS's NAICS code is 62 - Health Care and Social Assistance.

How many employees does MEDS have currently?

As of May 2026, MEDS has approximately 143 employees across 5 continents, including North AmericaSouth AmericaAfrica. Key team members include Ceo: J. T.Chief Financial Officer: J. C.Vice President Of New Business Development: C. P.. Explore MEDS's employee directory with LeadIQ.

What industry does MEDS belong to?

MEDS operates in the Hospitals and Health Care industry.

What technology does MEDS use?

MEDS's tech stack includes DisqusMySQLMailchimpPHPYoast SEOX-XSS-ProtectionCivicThemeNginx.

What is MEDS's email format?

MEDS's email format typically follows the pattern of First.Last@er-meds.com. Find more MEDS email formats with LeadIQ.

When was MEDS founded?

MEDS was founded in 1983.

MEDS

Q: What is MEDS's official website and social media links?

MEDS's official website is er-meds.com. MEDS has social profiles on LinkedIn.

Q: How many employees does MEDS have currently?

MEDS has approximately 143 employees.

Q: What technology does MEDS use?

MEDS's tech stack includes Mailchimp, PHP, Google Fonts API, Microsoft IIS, oEmbed.

Q: What is MEDS's NAICS code?

MEDS's NAICS code is 62 (Health Care and Social Assistance).

Hospitals and Health CareIllinois, United States51-200 Employees

Its primary customers are hospitals and physicians seeking reliable, optimized emergency care delivery and staffing support. MEDS emphasizes accessibility and responsiveness as key aspects of its service, aiming to support the ongoing success of its clients. With a mid-sized workforce, the company positions itself as a practical, specialized provider within the health care industry.